The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Laurence Albiges Consulting or Advisory Role - Astellas Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Telix Pharmaceuticals (Inst) Travel, Accommodations, Expenses - BMS; Ipsen; MSD; Pfizer   Kenichi Harano Employment - National Cancer Center Hospital East Consulting or Advisory Role - AstraZeneca; Chugai Pharma Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; MSD; Taiho Oncology; Takeda Research Funding - AstraZeneca; Chugai Pharma; Daiichi Sankyo; MSD; Takeda   Kathleen Moore Leadership - GOG Partners; NRG Oncology (Inst) Honoraria - Astellas Medivation; BIOPHARM; CEA/CCO; CME Outfitters; Congress Chanel; Curio Science; Great Debates and Updates; IDEOlogy Health; MDoutlook; Med Learning Group; Medscape; OncLive/MJH Life Sciences; Peerview; PeerVoice; Physicans' Education Resource; Plexus; Research to Practice; The Clearity Foundation; University of Arkansas for Medical Sciences; University of Florida; virtual incision Consulting or Advisory Role - AADi; Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; BioNTech SE; Bristol Myers Squibb Foundation; Caris Life Sciences; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo Europe GmbH; Day One Biopharmaceuticals; Debiopharm Group; Duality Biologics (Inst); Eisai; Foundation Medicine; Genentech/Roche; Genmab/Seagen; GlaxoSmithKline/Tesaro (Inst); immunocore; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Karyopharm Therapeutics; Kivu; Loxo/Lilly; Merck; Mersana (Inst); natera; Novocure; OnCusp Therapeutics; ProfoundBio; Regeneron; Roche; Schrodinger (Inst); seagen; T knife; Takeda Science Foundation; Tango Therapeutics; Third Arc; Tubulis GmbH; Verastem/Pharmacyclics; Whitehawk; zentalis; zymeworks Research Funding - Allarity Therapeutics (Inst); AstraZeneca (Inst); Daiichi Sankyo/Lilly (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Immunogen (Inst); Merck (Inst); Regeneron (Inst); Schrodinger (Inst); Torl Biotherapeutics (Inst); Verastem (Inst); Zymeworks (Inst) Other Relationship - GOG Partners (Inst) (OPTIONAL) Uncompensated Relationships - International Gynecologic Cancer Society   Susana Banerjee Stock and Other Ownership Interests - Innotive Diagnostics; Perci Health Honoraria - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; Immunogen; MSD Oncology; Pharmaand; Verastem Consulting or Advisory Role - Abbvie; Astrazeneca; Biogene; BioNTech SE; Eisai; Genmab; Gilead Sciences; GlaxoSmithKline; Grey Wolf Therapeutics; Immunogen; Incyte; ITM Oncologics; Lilly; MSD Oncology; Myriad Genetics; Seagen; Torl Biotherapeutics; Verastem; Zymeworks Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst) Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Verastem; Zymeworks (OPTIONAL) Uncompensated Relationships - International Cancer Foundation; Royal Society of Medicine President Oncology Session   Toon Van Gorp Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); BioNTech SE (Inst); Daiichi Sankyo (Inst); Eisai Europe (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MSD/Merck (Inst); OncXerna Therapeutics (Inst); PharmaAnd (Inst); Seagen (Inst); Torl Biotherapeutics (Inst); Tubulis GmbH (Inst); Verastem (Inst); Zentalis (Inst) Speakers' Bureau - Abbvie (Inst); AstraZeneca (Inst); Eisai (Inst); GlaxoSmithKline (Inst); MSD (Inst) Research Funding - Amgen (Inst); AstraZeneca (Inst); Roche (Inst) Travel, Accommodations, Expenses - AstraZeneca (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); MSD/Merck (Inst); PharmaMar (Inst)   Laura Palmeri Employment - Daiichi Sankyo Europe GmbH   Teddy Grand Employment - Daiichi Sankyo Travel, Accommodations, Expenses - Daiichi Sankyo   Soham Mahato Employment - Daiichi Sankyo; Novavax Stock and Other Ownership Interests - Lilly; Novavax; Pfizer   Jie Lin Employment - Daiichi Sankyo Stock and Other Ownership Interests - Daiichi Sankyo   Petar Jelinic Stock and Other Ownership Interests - Merck   Thomas Powles Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche